Stock comparison

LLYvsNVDA

Eli Lilly and Co vs NVIDIA Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

LLY

Eli Lilly and Co

$927.03

-6.70%

Pharmaceuticals$884.0BNYSE

NVDA

NVIDIA Corp

$201.68

+5.85%

Semiconductors$4.34TNASDAQ

60-day price, rebased to 100

LLY -12.77% · NVDA +5.52%

Round-by-round

LLY 1·NVDA 4· 1 tie

EdgeLLY

Valuation upside

-92.70% vs -98.20% to DCF fair value

EdgeNVDA

Balance-sheet strength

Altman Z 15.74 vs 512.92

Tie

Fundamental quality

Piotroski 6.00 vs 6.00 (of 9)

EdgeNVDA

Growth + margins

Rule-of-40 -9.10 vs -6.80

EdgeNVDA

60-day momentum

-12.77% vs +5.52% price return

EdgeNVDA

Market-cap liquidity

$884.0B vs $4.34T

Verdict

Across 6 categories, NVDA takes the edge with 4 wins to 1 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy on LLY or NVDA

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.